Wu M, Wang H, Wu X, Zeng H, Miao M, Song Y
J Hepatocell Carcinoma. 2025; 12:467-480.
PMID: 40061164
PMC: 11887506.
DOI: 10.2147/JHC.S500638.
Zhu B, Cheng L, Huang B, Liu R, Ren B
Medicine (Baltimore). 2024; 103(44):e40273.
PMID: 39496001
PMC: 11537650.
DOI: 10.1097/MD.0000000000040273.
Wong P, Chan C, Xue H, Goh C, Cheu J, Tse A
JCI Insight. 2024; 9(22).
PMID: 39388278
PMC: 11601891.
DOI: 10.1172/jci.insight.170532.
Telouk P, Plissonnier M, Merle P, Zoulim F, Fares N, Guilloreau P
Gastro Hep Adv. 2024; 1(3):480-486.
PMID: 39131686
PMC: 11307693.
DOI: 10.1016/j.gastha.2022.02.024.
Cagnin S, Pontisso P, Martini A
Cancers (Basel). 2024; 16(14).
PMID: 39061218
PMC: 11274807.
DOI: 10.3390/cancers16142579.
Harnessing CD8 T cell dynamics in hepatitis B virus-associated liver diseases: Insights, therapies and future directions.
Yue B, Gao Y, Hu Y, Zhan M, Wu Y, Lu L
Clin Transl Med. 2024; 14(7):e1731.
PMID: 38935536
PMC: 11210506.
DOI: 10.1002/ctm2.1731.
Chip collection of hepatocellular carcinoma based on O heterogeneity from patient tissue.
Baek S, Ha H, Park J, Cho M, Kim H, Yu S
Nat Commun. 2024; 15(1):5117.
PMID: 38879551
PMC: 11180182.
DOI: 10.1038/s41467-024-49386-8.
The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure.
Mucke M, El Bali N, Schwarzkopf K, Uschner F, Kraus N, Eberle L
Int J Mol Sci. 2024; 25(3).
PMID: 38338821
PMC: 10855542.
DOI: 10.3390/ijms25031542.
HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathway.
Xu M, Warner C, Duan X, Cheng Z, Jeyarajan A, Li W
J Hepatol. 2024; 80(6):868-881.
PMID: 38311121
PMC: 11102332.
DOI: 10.1016/j.jhep.2024.01.026.
Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma.
Liu J, Park K, Shen Z, Lee H, Geetha P, Pakyari M
Front Immunol. 2024; 14:1285370.
PMID: 38173713
PMC: 10762788.
DOI: 10.3389/fimmu.2023.1285370.
Signaling metabolite succinylacetone activates HIF-1α and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma.
Luo H, Wang Q, Yang F, Liu R, Gao Q, Cheng B
JCI Insight. 2023; 8(23).
PMID: 37906252
PMC: 10896004.
DOI: 10.1172/jci.insight.164968.
Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma.
Guerra P, Martini A, Pontisso P, Angeli P
Cancers (Basel). 2023; 15(14).
PMID: 37509293
PMC: 10377787.
DOI: 10.3390/cancers15143629.
Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: in silico and in vivo studies of the involvement of Akt.
Akinloye D, Metibemu D, Shittu M, Lawal M, Olatunji F, Oyediran M
J Cannabis Res. 2023; 5(1):27.
PMID: 37434213
PMC: 10337064.
DOI: 10.1186/s42238-023-00190-z.
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies.
Pinto E, Pelizzaro F, Farinati F, Russo F
Medicina (Kaunas). 2023; 59(6).
PMID: 37374319
PMC: 10305396.
DOI: 10.3390/medicina59061115.
Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma.
Huynh K, Rao S, Roth B, Bryan T, Fernando D, Dayyani F
Cancers (Basel). 2023; 15(10).
PMID: 37345074
PMC: 10216171.
DOI: 10.3390/cancers15102738.
miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism.
Hu Y, Setayesh T, Vaziri F, Wu X, Hwang S, Chen X
Mol Ther. 2023; 31(6):1829-1845.
PMID: 37143325
PMC: 10277895.
DOI: 10.1016/j.ymthe.2023.04.019.
Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia.
Dolly A, Potgens S, Thibaut M, Neyrinck A, de Castro G, Galbert C
J Cachexia Sarcopenia Muscle. 2023; 14(3):1569-1582.
PMID: 37127348
PMC: 10235873.
DOI: 10.1002/jcsm.13246.
Role of Hydrogen Sulfide and Hypoxia in Hepatic Angiogenesis of Portal Hypertension.
Yang H, Tan M, Gao Z, Wang S, Lyu L, Ding H
J Clin Transl Hepatol. 2023; 11(3):675-681.
PMID: 36969894
PMC: 10037502.
DOI: 10.14218/JCTH.2022.00217.
Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib.
Jiang Z, Dai C
J Hepatocell Carcinoma. 2023; 10:257-266.
PMID: 36815094
PMC: 9939808.
DOI: 10.2147/JHC.S396231.
Prospective Analysis of Proteins Carried in Extracellular Vesicles with Clinical Outcome in Hepatocellular Carcinoma.
Chen W, Zhang F, Xu H, Hou X, Tang D
Curr Genomics. 2023; 23(2):109-117.
PMID: 36778976
PMC: 9878836.
DOI: 10.2174/1389202923666220304125458.